P. Krause

发表

Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs

N. Bourne, L. Stanberry, S. Straus, 1995, The Journal of experimental medicine.

The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region

L. Stanberry, N. Bourne, L. Stanberry, 1996, The Journal of experimental medicine.

Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice

A. Ellison, T. Margolis, P. Krause, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Spread of Herpes Simplex Virus to the Spinal Cord Is Independent of Spread to Dorsal Root Ganglia

P. Krause, M. Ohashi, A. Bertke, 2010, Journal of Virology.

Postlicensure safety surveillance for varicella vaccine.

M. Braun, M. Salive, L. Rider, 2000, JAMA.

Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes

D. Bernstein, T. Foster, D. Knipe, 2014, Science Translational Medicine.

Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia

G. Illei, J. Cohen, J. Gea-Banacloche, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

Use of a universal virus detection assay to identify human metapneumovirus in a hematopoietic stem cell transplant recipient with pneumonia of unknown origin.

J. Cohen, Daniel F Fedorko, P. Krause, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Herpes Simplex Virus Type 2 (HSV-2) Establishes Latent Infection in a Different Population of Ganglionic Neurons than HSV-1: Role of Latency-Associated Transcripts

T. Margolis, P. Krause, Li Yang, 2006, Journal of Virology.

Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers

Rosanna Lagos, M. Levine, K. Subbarao, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

B. Savarese, C. Dekker, L. Corey, 1994, The Lancet.

Approaches to demonstration of Ebola virus vaccine efficacy.

M. Cavaleri, M. Gruber, P. Krause, 2015, The Lancet. Infectious diseases.

Regulatory Approaches for Control of Viral Contamination of Vaccines

P. Krause, C. Uhlenhaut, S. McClenahan, 2011, PDA Journal of Pharmaceutical Science and Technology.

Molecular and infectivity studies of porcine circovirus in vaccines.

P. Krause, C. Uhlenhaut, S. McClenahan, 2011, Vaccine.

Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA.

P. Krause, A. Sierra-Honigmann, 2000, Biologicals : journal of the International Association of Biological Standardization.

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential

T. Fleming, S. Ellenberg, E. Halloran, 2020, The Lancet.

Downstream regulatory elements increase acute and latent herpes simplex virus type 2 latency-associated transcript expression but do not influence recurrence phenotype or establishment of latency

N. Bourne, L. Stanberry, P. Krause, 1996, Journal of virology.

Virus assay using antibody-functionalized peptide nanotubes.

H. Matsui, I. Banerjee, R. MacCuspie, 2008, Soft matter.

Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis

H. Einsele, F. Baldanti, G. Fahle, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Quantity of latency-associated transcript produced by herpes simplex virus is not predictive of the frequency of experimental recurrent genital herpes.

N. Bourne, L. Stanberry, S. Straus, 1994, The Journal of infectious diseases.

Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides.

K. Ishii, D. Singer, D. Klinman, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of HSV-2 primary miRNA 1 transcript regulation 2 3 4

T. Margolis, P. Krause, Amita Patel, 2015 .

Herpes Simplex Virus 2 expresses a novel form of ICP 34 . 5 , a 1 major viral neurovirulence factor , through regulated 2 alternative splicing

P. Krause, Amita Patel, Shuāng Táng, 2013 .

Universal virus detection by degenerate-oligonucleotide primed polymerase chain reaction of purified viral nucleic acids

P. Krause, Amita Patel, C. Uhlenhaut, 2008, Journal of Virological Methods.

Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.

T. Yoshikawa, J. Cohen, P. Krause, 2000, The Journal of infectious diseases.

Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates

A. Wilder-Smith, J. Hombach, M. Cavaleri, 2019, Vaccine.

Reverse Engineering of Vaccine Antigens Using High Throughput Sequencing-enhanced mRNA Display

Hongying Duan, M. Major, P. Krause, 2015, EBioMedicine.

Glutamine supplementation suppresses herpes simplex virus reactivation

T. Myers, Kennichi C. Dowdell, J. Cohen, 2017, The Journal of clinical investigation.

Hidden regulation of herpes simplex virus 1 pre-mRNA splicing and polyadenylation by virally encoded immediate early gene ICP27

P. Krause, Amita Patel, Shuāng Táng, 2019, PLoS pathogens.

Epinephrine and outcome after cardiac arrest.

S. Straus, P. Krause, P. Brunell, 1999, Annals of internal medicine.

Tendency to serious sequelae of infection with the human immunodeficiency virus in sibships with hemophilia.

M. Lederman, N. Meropol, P. Levine, 1989, Archives of internal medicine.

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply

S. Swaminathan, P. Krause, A. Restrepo, 2022, The Lancet.

Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine.

D. Klinman, P. Krause, Philip R. Krause, 1995, The Journal of pediatrics.

Varicella vaccination: Evidence for frequent reactivation of the vaccine strain in healthy children

D. Klinman, P. Krause, 2000, Nature Medicine.

Herpesvirus vaccines. Development, controversies, and applications.

S. Straus, P. Krause, 1999, Infectious disease clinics of North America.

Herpes Simplex Virus 2 MicroRNA miR-H6 Is a Novel Latency-Associated Transcript-Associated MicroRNA, but Reduction of Its Expression Does Not Inﬂuence the Establishment of Viral Latency or the Recurrence Phenotype (cid:1)

T. Margolis, P. Krause, A. Bertke, 2011 .

Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine.

D. Margolis, B. Savarese, S. Straus, 1993, The Journal of infectious diseases.

Herpes Simplex Virus 2 Expresses a Novel Form of ICP34.5, a Major Viral Neurovirulence Factor, through Regulated Alternative Splicing

P. Krause, Amita Patel, Shuāng Táng, 2013, Journal of Virology.

Improved Identification and Differentiation of Varicella-Zoster Virus (VZV) Wild-Type Strains and an Attenuated Varicella Vaccine Strain Using a VZV Open Reading Frame 62-Based PCR

V. Loparev, P. Krause, D. Schmid, 2000, Journal of Clinical Microbiology.

Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.

V. Beral, R. Peto, T. Fleming, 2020, The New England journal of medicine.

Considerations in boosting COVID-19 vaccine immune responses

Michael J. Ryan, J. Sterne, R. Peto, 2021, The Lancet.

Use of DOP-PCR in Non-Specific Virus Detection

P. Krause, C. Uhlenhaut, S. McClenahan, 2011, PDA Journal of Pharmaceutical Science and Technology.

Simian Cytomegalovirus Encodes Five Rapidly Evolving Chemokine Receptor Homologues

P. Murphy, P. Krause, A. Sahagún-Ruiz, 2004, Virus Genes.

Clinical Development Strategies and Considerations for Zika Vaccine Licensure

D. Fink, T. Finn, P. Marks, 2017, The Journal of infectious diseases.

Evidence for frequent reactivation of the Oka varicella vaccine strain in healthy vaccinees.

P. Krause, 2001, Archives of virology. Supplementum.

SARS-CoV-2 Variants and Vaccines

Michael J. Ryan, V. Beral, R. Peto, 2021, The New England journal of medicine.

Detection of enteric adenoviruses by dot‐blot hybridization using a molecularly cloned viral DNA probe

R. Yolken, S. Straus, M. Seidlin, 1985, Journal of medical virology.

Interim results from a phase 3 Ebola vaccine study in Guinea

P. Krause, 2015, The Lancet.

Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

G. Hortin, T. Walsh, T. Zaoutis, 2008, Clinica chimica acta; international journal of clinical chemistry.

Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.

M. Levin, R. Giller, A. Weinberg, 2003, The Journal of infectious diseases.

Latency-Associated Transcript (LAT) Exon 1 Controls Herpes Simplex Virus Species-Specific Phenotypes: Reactivation in the Guinea Pig Genital Model and Neuron Subtype-Specific Latent Expression of LAT

T. Margolis, P. Krause, A. Bertke, 2009, Journal of Virology.

Characterization of Herpes Simplex Virus 2 Primary MicroRNA Transcript Regulation

T. Margolis, P. Krause, Amita Patel, 2015, Journal of Virology.

The Potential Role of Advanced Technologies for Virus Detection in Development and Regulation of Vaccines

Philip R Krause, Shasta D McClenahan, P. Krause, 2014, PDA Journal of Pharmaceutical Science and Technology.

Herpes Simplex Virus Latency-Associated Transcript Sequence Downstream of the Promoter Influences Type-Specific Reactivation and Viral Neurotropism

P. Krause, A. Bertke, Amita Patel, 2007, Journal of Virology.

Herpes Simplex Virus 2 in Autonomic Ganglia: Evidence for Spontaneous Reactivation

P. Krause, A. Bertke, Julianna R Pieknik, 2019, Journal of Virology.

HSV-2 in Autonomic Ganglia: Evidence for Spontaneous Reactivation

P. Krause, A. Bertke, Julianna R Pieknik, 2019 .

A VP26-mNeonGreen Capsid Fusion HSV-2 Mutant Reactivates from Viral Latency in the Guinea Pig Genital Model with Normal Kinetics

P. Krause, A. Bertke, Shuāng Táng, 2018, Viruses.

Discovery of a Bovine Enterovirus in Alpaca

L. Borst, R. Fredrickson, P. Krause, 2013, PloS one.

Herpes Simplex Virus 2 Latency-Associated Transcript (LAT) Region Mutations Do Not Identify a Role for LAT-Associated MicroRNAs in Viral Reactivation in Guinea Pig Genital Models

P. Krause, Amita Patel, Shuāng Táng, 2018, Journal of Virology.

Herpes Simplex Virus 2 MicroRNA miR-H6 Is a Novel Latency-Associated Transcript-Associated MicroRNA, but Reduction of Its Expression Does Not Influence the Establishment of Viral Latency or the Recurrence Phenotype

T. Margolis, P. Krause, A. Bertke, 2011, Journal of Virology.

An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor

J. Cohen, P. Krause, Kening Wang, 2008, Proceedings of the National Academy of Sciences.

An HSV-1 chimeric containing HSV-2 latency associated transcript (LAT) sequences has significantly reduced adrenergic reactivation in the rabbit eye model

James M. Hill, P. Krause, Amita Patel, 2003, Current eye research.

The 2.2-Kilobase Latency-Associated Transcript of Herpes Simplex Virus Type 2 Does Not Modulate Viral Replication, Reactivation, or Establishment of Latency in Transgenic Mice

E. Guancial, S. Straus, P. Krause, 2001, Journal of Virology.

Analysis of the promoter and cis-acting elements regulating expression of herpes simplex virus type 2 latency-associated transcripts

S. Straus, P. Krause, K. Wang, 1995, Journal of virology.

Investigation of the Mechanism by Which Herpes Simplex Virus Type 1 LAT Sequences Modulate Preferential Establishment of Latent Infection in Mouse Trigeminal Ganglia

W. Halford, T. Margolis, P. Krause, 2009, Journal of Virology.

The nucleotide sequence, 5' end, promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency-associated transcript

S. Straus, J. Ostrove, P. Krause, 1991, Journal of virology.

Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia

S. Straus, J. Ostrove, K. Croen, 1988, Journal of virology.

Structural and kinetic analyses of herpes simplex virus type 1 latency-associated transcripts in human trigeminal ganglia and in cell culture.

S. Straus, J. Ostrove, K. Croen, 1990, The Journal of clinical investigation.

Identification of Viral MicroRNAs Expressed in Human Sacral Ganglia Latently Infected with Herpes Simplex Virus 2

B. Cullen, J. Cohen, J. L. Umbach, 2009, Journal of Virology.

A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats

J. Glorioso, W. Goins, L. Sternberg, 1994, Journal of virology.

Development of herpes simplex virus disease in patients who are receiving cidofovir.

D. Wyles, A. Weinberg, P. Krause, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Desirability and feasibility of a vaccine against cytomegalovirus.

P. Griffiths, S. Plotkin, M. Schleiss, 2013, Vaccine.

Novel Less-Abundant Viral MicroRNAs Encoded by Herpes Simplex Virus 2 Latency-Associated Transcript and Their Roles in Regulating ICP34.5 and ICP0 mRNAs

P. Krause, Amita Patel, Shuāng Táng, 2008, Journal of Virology.

Herpes simplex virus ICP27 regulates alternative pre-mRNA polyadenylation and splicing in a sequence-dependent manner

P. Krause, Amita Patel, Shuāng Táng, 2016, Proceedings of the National Academy of Sciences.

Priorities for CMV vaccine development.

P. Griffiths, S. Boppana, P. Ljungman, 2013, Vaccine.

Zoster and its complications.

S. Straus, P. Krause, 1990, Hospital practice.

Optimization of virus detection in cells using massively parallel sequencing.

P. Krause, C. Uhlenhaut, S. McClenahan, 2014, Biologicals : journal of the International Association of Biological Standardization.

Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19

S. Rubin, M. Gruber, P. Krause, 2023, Frontiers in Immunology.

Regulating vaccines at the FDA: development and licensure of Zika vaccines

M. Gruber, P. Krause, 2017, Expert review of vaccines.

Immunology of protection from Ebola virus infection

N. Michael, M. Gruber, P. Krause, 2015, Science Translational Medicine.

Animal models for COVID-19

Lisa E. Gralinski, J. Chan, J. Segalés, 2020, Nature.

Report of the international conference on next generation sequencing for adventitious virus detection in biologicals.

Arifa S Khan, Luca Benetti, Johannes Blumel, 2018, Biologicals : journal of the International Association of Biological Standardization.

Evaluation of cells and biological reagents for adventitious agents using degenerate primer PCR and massively parallel sequencing.

P. Krause, C. Uhlenhaut, S. McClenahan, 2014, Vaccine.

Pharmacoepidemiologic implications of erroneous varicella vaccinations in pregnancy through confusion with Varicella zoster immune globulin

M. Braun, M. Salive, J. Seward, 2002, Pharmacoepidemiology and drug safety.

Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.

M. Gruber, P. Krause, 2020, The New England journal of medicine.

COVID-19 vaccine trials: The use of active controls and non-inferiority studies

T. Fleming, I. Longini, P. Krause, 2021, Clinical trials.

Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.

Philip R Krause, Thomas Jaki, M Elizabeth Halloran, 2020, The New England journal of medicine.

Towards dynamic monitoring of cell cultures using high throughput sequencing.

P. Krause, S. McClenahan, 2019, Vaccine.

A Sensitive Peptide-Nanotube Based Pathogen Assay

H. Matsui, I. Banerjee, R. MacCuspie, 2006 .

The comparative biology of latent herpes simplex virus type 1 and type 2 infections: latency-associated transcript promoter activity and expression in vitro and in infected mice.

S. Straus, P. Krause, L. Pesnicak, 1998, Journal of neurovirology.

Structural and Kinetic Analyses of Herpes Simplex Virus Type I Latency-associated Transcripts in Human Trigeminal Ganglia and in Cell Culture

S. Straus, J. Ostrove, K. Croen, 2022 .

Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older

R. Forshee, T. MaCurdy, R. Harpaz, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Goals of stability evaluation throughout the vaccine life cycle.

P. Krause, 2009, Biologicals : journal of the International Association of Biological Standardization.

Rapid Genotyping of Varicella-Zoster Virus Vaccine and Wild-Type Strains with Fluorophore-Labeled Hybridization Probes

V. Loparev, P. Krause, B. Holloway, 2000, Journal of Clinical Microbiology.

Safety of viral DNA in biological products.

P. Krause, A. Lewis, 1998, Biologicals : journal of the International Association of Biological Standardization.

62-Based PCR Strain Using a VZV Open Reading Frame Strains and an Attenuated Varicella Vaccine of Varicella-Zoster Virus (VZV) Wild-Type Improved Identification and Differentiation

V. Loparev, P. Krause, D. Schmid, 2013 .

Live oral poliovirus vaccines and simian cytomegalovirus.

P. Krause, A. Sierra-Honigmann, 2002, Biologicals : journal of the International Association of Biological Standardization.

Stability evaluation of vaccines.

T. Schofield, P. Krause, 2009, Biologicals (Print).

U.S. Regulatory Issues Related to Vaccines against Emerging Infectious Diseases

P. Krause, 2009 .

Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines.

P. Krause, Jeffrey N Roberts, 2020, The Journal of infectious diseases.

Herpes Simplex Virus 2 Latency-Associated Transcript (LAT) Region Mutations Do Not Identify a Role for LAT-Associated MicroRNAs in Viral Reactivation in Guinea Pig Genital Models

P. Krause, Amita Patel, Shuāng Táng, 2018, Journal of Virology.

An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor

J. Cohen, P. Krause, Kening Wang, 2008, Proceedings of the National Academy of Sciences.